WAM
Wolverine Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-57,333
| Closed | -$2.14M | – | 2035 |
|
|
2022
Q2 | $2.14M | Buy |
57,333
+20,346
| +55% | +$758K | 0.02% | 393 |
|
|
2022
Q1 | $1.64M | Buy |
36,987
+17,094
| +86% | +$757K | 0.02% | 437 |
|
|
2021
Q4 | $845K | Buy |
+19,893
| New | +$845K | 0.01% | 647 |
|
|
2021
Q3 | – | Sell |
-12,402
| Closed | -$530K | – | 1690 |
|
|
2021
Q2 | $530K | Sell |
12,402
-11,026
| -47% | -$471K | ﹤0.01% | 707 |
|
|
2021
Q1 | $905K | Sell |
23,428
-342,825
| -94% | -$13.2M | 0.01% | 542 |
|
|
2020
Q4 | $13.2M | Buy |
366,253
+306,430
| +512% | +$11M | 0.1% | 122 |
|
|
2020
Q3 | $2.29M | Buy |
59,823
+59,269
| +10,698% | +$2.26M | 0.02% | 271 |
|
|
2020
Q2 | $19K | Buy |
+554
| New | +$19K | ﹤0.01% | 1067 |
|
|
2019
Q2 | – | Sell |
-2,902
| Closed | -$111K | – | 1040 |
|
|
2019
Q1 | $111K | Buy |
+2,902
| New | +$111K | ﹤0.01% | 772 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 821 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 765 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1128 |
|
|
2014
Q3 | – | Sell |
-4,700
| Closed | -$60K | – | 1164 |
|
|
2014
Q2 | $60K | Buy |
+4,700
| New | +$60K | ﹤0.01% | 850 |
|
|
2014
Q1 | – | Sell |
-30,000
| Closed | -$360K | – | 1133 |
|
|
2013
Q4 | $360K | Sell |
30,000
-100
| -0.3% | -$1.2K | 0.01% | 704 |
|
|
2013
Q3 | $353K | Buy |
30,100
+29,100
| +2,910% | +$341K | 0.01% | 684 |
|
|
2013
Q2 | $9K | Buy |
+1,000
| New | +$9K | ﹤0.01% | 1067 |
|